Evaluation of Paclitaxel in Patients With CLI (Critical Limb Ischemia) and Femoropopliteal Occlusive Disease Treated With DCB Angioplasty
Latest Information Update: 30 Apr 2024
At a glance
- Drugs Paclitaxel (Primary)
- Indications Chronic limb-threatening ischemia
- Focus Therapeutic Use
Most Recent Events
- 23 Apr 2024 Status changed from active, no longer recruiting to completed.
- 22 Apr 2024 The protocol has been amended to decrease in study time frame for Primary endpoint up to 6 months.
- 02 Mar 2023 Planned End Date changed from 31 Dec 2022 to 31 Dec 2023.